Sleep Cycle (Q4 Initial take): Muted topline but solid margins; Pivot weighs on 2026 outlook - Redeye

Sleep Cycle’s Q4 report was in line with our top-line expectations but revealed a steeper-than-anticipated decline in the subscriber base. While the company maintained solid profitability—exceeding its 25% EBIT target for the full year—the outlook for 2026 is dampened by a heavy investment phase into MedTech and B2B initiatives. Consequently, management expects a temporary contraction in both revenue and margins next year. We anticipate lowering our near-term forecast.

Länk till analysen i sin helhet: https://www.redeye.se/research/1146156/sleep-cycle-q4-initial-take-muted-topline-but-solid-margins-pivot-weighs-on-2026-outlook?utm_source=finwire&utm_medium=RSS